Division of Cancer Epidemiology & Genetics

Publications

Scientific Talks from Symposium Honoring Joseph Fraumeni

DCEG hosted "Cancer Epidemiology: From Pedigrees to Populations," a scientific symposium honoring 50 years of visionary leadership by Dr. Joseph F. Fraumeni, Jr. Presentations from the event are now available to view online.

•	Watch scientific talks from the symposium
•	Learn more about Dr. Fraumeni

Pleuropulmonary Blastoma Cancer Study

Dr. Douglas Stewart and collaborators study pleuropulmonary blastoma (PPB), a rare pediatric cancer that is part of an inherited cancer predisposition syndrome caused by changes in the DICER1 gene. This study is currently recruiting children and family members with PPB or related tumors and conditions.

•	Learn more about the PPB Cancer Study
•	Read more about Dr. Stewart

Spotlight on Population Research:
Aimée Kreimer

Dr. Aimée Kreimer, a tenure-track investigator in the Infections and Immunoepidemiology Branch, discusses her research on human papillomavirus and cancer.

•	Watch the video spotlight of Dr. Kreimer
•	Learn more about Dr. Kreimer

Fraumeni Symposium Scientific Talks
Pleuropulmonary Blastoma Cancer Study
Spotlight on Population Research: Aimée Kreimer

The Division of Cancer Epidemiology and Genetics (DCEG) is a research program of the National Cancer Institute (NCI), one of the National Institutes of Health (NIH). The Division is the world’s most comprehensive cancer epidemiology research group. Its renowned epidemiologists, geneticists, and biostatisticians conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Division’s research impacts public health policy in the United States and around the world.